logo

Stock Screener

Forex Screener

Crypto Screener

VERO

Venus Concept Inc. (VERO)

$

2.93

+0.25 (8.53%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

-20.6361

Market cap

Market cap

5.4 Million

Price to sales ratio

Price to sales ratio

0.1150

Debt to equity

Debt to equity

10.9054

Current ratio

Current ratio

1.2807

Income quality

Income quality

0.2926

Average inventory

Average inventory

17.6 Million

ROE

ROE

-10.7517



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

The financial data pertains to the fiscal year 2024. The company recorded an operating income of -$27,184,000.00 reflecting its earnings from core operations. Additionally, the diluted EPS is -$66.28 accounting for potential share dilution. The company reported depreciation and amortization expenses of $3,889,000.00 reflecting the wear and tear of its assets. Furthermore, the cost of revenue for the company is $20,527,000.00 showcasing its production and operational expenses. Venus Concept Inc. develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, along with related services both in the United States and internationally. Its diverse product portfolio features aesthetic device platforms like Venus Legacy, a non-invasive device utilized in dermatological and surgical procedures; Venus Versa, a versatile device for various aesthetic and cosmetic treatments; and Venus Viva, an advanced portable fractional RF system for dermatological procedures focused on skin ablation and resurfacing. The stock is affordable at $2.93 making it suitable for budget-conscious investors. It has a high average trading volume of 1,711,200.00 indicating strong liquidity in the marketplace. With a market capitalization of $5,447,222.00 the company is classified as a small-cap player. As a key player in the Medical - Devices industry, Venus Concept Inc. contributes significantly to the overall market landscape and continues to innovate within the sector. Additionally, it belongs to the Healthcare sector, driving innovation and growth through its cutting-edge technologies. Among its offerings are Venus Fiore for treating various medical conditions, Venus Bliss for non-invasive body contouring, and NeoGraft, an automated hair restoration system. Venus Velocity and Venus Epileve assist in hair removal and the treatment of pseudofolliculitis barbae, while the ARTAS iX robotic system aids in hair follicle extraction and transplantation.

What is Venus Concept Inc. (VERO)'s current stock price?

The current stock price of Venus Concept Inc. (VERO) is $2.93 as of 2025-07-08. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Venus Concept Inc. (VERO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict Venus Concept Inc. stock to fluctuate between $2.10 (low) and $14.50 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-07-08, Venus Concept Inc.'s market cap is $5,447,222, based on 1,859,120 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, Venus Concept Inc. has a Lower Market-Cap, indicating a difference in performance.

To buy Venus Concept Inc. (VERO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VERO. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Venus Concept Inc.'s last stock split was 1:11 on 2025-03-04.

Revenue: $64,833,000 | EPS: -$66.28 | Growth: 869.01%.

Visit https://www.venusconcept.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $567.60 (2021-02-22) | All-time low: $2.10 (2025-05-16).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

VERO

globenewswire.com

Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG Co. Ltd (“Meta Healthcare Group”) in an all-cash transaction valued at $20 million, subject to a customary working capital adjustment. The net proceeds from the transaction, once completed, will enhance the Company's balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives.

VERO

seekingalpha.com

Venus Concept Inc. (VERO) Q1 2025 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2025 Earnings Conference Call for Venus Concept Inc. At this time all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

VERO

globenewswire.com

Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025

TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, May 15, 2025.

VERO

seekingalpha.com

Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Marie Thibault - BTIG Jeremy Pearlman - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

VERO

globenewswire.com

Venus Concept Announces 1-for-11 Reverse Stock Split

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 5:00 p.m. Eastern Standard Time on March 3, 2025. The Company's common stock is expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis at the open of trading on March 4, 2025.

VERO

seekingalpha.com

Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Sam Eiber - BTIG Thomas McGovern - Maxim Group Operator Please standby. Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Earnings Conference Call for Venus Concept Incorporated.

VERO

globenewswire.com

Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2024.

VERO

globenewswire.com

Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets

VERO

globenewswire.com

Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, November 13, 2024.

VERO

globenewswire.com

Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction

Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener